US 9951010
Compounds as CRTH2 antagonist and uses thereof
granted A61KA61K31/405A61K31/4375
Quick answer
US patent 9951010 (Compounds as CRTH2 antagonist and uses thereof) held by SUNSHINE LAKE PHARMA CO., LTD. expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- SUNSHINE LAKE PHARMA CO., LTD.
- Grant date
- Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K31/405, A61K31/4375, A61K31/4439, A61K31/454